Patent · US Active

17Beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of hormone-related diseases

US8546392B2 · kind B2 · utility

34Cited by

1References

8Claims

0Family size

Assignee

UNIVERSITAT DES SAARLANDES · DE

Inventors

Rolf Hartmann · Saarburg, DE
Martin Frotscher · Pocking, DE
Sandrine Oberwinkler · Blieskastel, DE
Erika Ziegler · Aichach, DE
Josef Messinger · Sehnde, DE
Heinrich-Hubert Thole · Hannover, DE

Key dates

Filing date	Mar 27, 2008
Grant date	Oct 1, 2013
Priority date	—
Expiry date	Jun 21, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the use of non-steroidal 17beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment and prophylaxis of hormone-dependent, particularly estrogen-dependent, diseases. The invention further relates to suitable inhibitors and to a method for the production thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.